Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€2.81
24.12.22
-
24.12.23
-25.37%
01.11.23

Could be worthwhile Investment >10% per year
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€14.28
24.12.22
-
24.12.23
-
24.12.22

Could be worthwhile Investment >10% per year
buy
Hexo Corp.

Start price
Target price
Perf. (%)
€0.91
24.12.22
-
24.12.23
-31.30%
29.07.23

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good culture
Future proof or reliable business model
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€14.28
23.12.22
-
-
24.12.22

Could be worthwhile Investment >10% per year
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€7.52
23.12.22
€9.00
30.09.25
-79.54%
12.11.23

Could be very worthwhile Investment >20% year
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€34.35
22.12.22
-
22.12.23
13.25%
24.08.23

buy
Glycomimetics Inc.

Start price
Target price
Perf. (%)
€2.05
21.12.22
€4.00
31.12.24
-34.96%
05.05.23

Could be very worthwhile Investment >20% year
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.32
21.12.22
€11.00
31.03.24
29.21%
28.12.22

Could be very worthwhile Investment >20% year
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€6.10
19.12.22
€18.00
31.12.24
226.15%
05.05.23

Could be very worthwhile Investment >20% year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.76
11.12.22
-
11.12.23
-6.82%
06.03.23

Could be worthwhile Investment >10% per year
buy
M1 Kliniken AG

Start price
Target price
Perf. (%)
€6.04
09.12.22
-
09.12.23
68.87%
10.12.23

buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.24
08.12.22
-
08.12.23
-6.85%
24.12.22

Risky Investment
buy
Medigene AG

Start price
Target price
Perf. (%)
€2.29
06.12.22
-
06.12.23
-33.62%
07.12.23

buy
Immunic Inc.

Start price
Target price
Perf. (%)
€1.33
27.11.22
-
27.11.23
-14.77%
11.12.22

Risky Investment
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.34
19.11.22
€0.10
19.11.23
-5.60%
27.02.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.80
19.11.22
€2.00
19.11.23
-41.00%
20.11.23

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€6.85
17.11.22
-
17.11.23
-17.52%
27.11.22

Risky Investment
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€7.15
13.11.22
-
13.11.23
-20.98%
26.11.22

Could be worthwhile Investment >10% per year
buy
Mediclin AG

Start price
Target price
Perf. (%)
€3.32
13.11.22
€3.00
13.11.23
-0.60%
26.11.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
buy
Acelrx Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.91
08.11.22
€4.20
08.11.23
23.85%
16.11.22

Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€38.20
04.11.22
€32.00
31.12.24
6.81%
21.12.22

Could be very worthwhile Investment >20% year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.62
03.11.22
-
03.11.23
13.26%
10.11.22

Could be very worthwhile Investment >20% year
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€42.60
01.11.22
€55.00
31.12.24
-10.33%
04.11.22

Could be very worthwhile Investment >20% year
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.47
31.10.22
€18.00
31.12.24
19.77%
31.10.22

Could be very worthwhile Investment >20% year
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€2.68
29.10.22
-
29.10.23
40.63%
30.10.23

Could be worthwhile Investment >10% per year